Introduction: Penile cancer is a rare malignant neoplasm in developed countries but has a high incidence in socioeconomically disadvantaged regions such as the Legal Amazon. Factors such as poor hygiene, HPV infection, lack of circumcision, and low educational levels contribute to the development and worsening of the disease. The analysis of deaths from this cause can support the formulation of effective public policies, especially in vulnerable areas. Objectives: To analyze deaths from penile cancer in the Legal Amazon between 2020 and 2023, using secondary data from the Cancer Information System (SISCAN), focusing on sociodemographic aspects. Methodology: Using a quantitative approach, a cross-sectional ecological study was conducted, utilizing publicly accessible data from DataSUS. Selected variables included the total distribution of deaths by race and age group. Results: From 2020 to 2023, approximately 500 deaths from penile cancer were recorded in the Legal Amazon, according to data extracted from SISCAN. A higher prevalence was observed among mixed-race men, with approximately 65% of cases, followed by white men (20%) and black men (10%). Regarding age groups, men between 60 and 69 years had the highest number of cases, accounting for 35% of deaths, followed by those aged 70 to 79 years (30%) and 50 to 59 years (20%). Various structural barriers and the predominance of deaths among self-identified mixed-race men reflect social and regional inequalities, hindering access to healthcare services. The data analyzed reflect structural inequalities in access to early diagnosis and appropriate treatment of penile cancer. Low coverage of educational campaigns focused on intimate hygiene, sexually transmitted infections (STIs) — particularly HPV — and the stigma associated with genital examinations exacerbate the situation. Furthermore, the concentration of deaths among older and mixed-race individuals highlights the critical role of social determinants of health in the progression of the disease. The findings indicate that numerous structural and socioeconomic barriers impact access to diagnosis and treatment, highlighting the urgent need for public policies aimed at health education, screening, and early treatment. Conclusions: The study reinforces the need to strengthen actions for prevention, screening, and early diagnosis, particularly in the state of Pará. It also emphasizes the importance of expanding access to oncology care, especially among men aged 70 to 79 years, a phase where timely screening can be crucial for early diagnosis.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
